2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American …

CM Otto, RA Nishimura, RO Bonow… - Journal of the American …, 2021 - jacc.org
Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey

B Iung, V Delgado, R Rosenhek, S Price… - Circulation, 2019 - Am Heart Assoc
Background: Valvular heart disease (VHD) is an important cause of mortality and morbidity
and has been subject to important changes in management. The VHD II survey was …

[HTML][HTML] Transcatheter mitral-valve repair in patients with heart failure

GW Stone, JA Lindenfeld, WT Abraham… - … England Journal of …, 2018 - Mass Medical Soc
Background Among patients with heart failure who have mitral regurgitation due to left
ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve …

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

SH Yoon, BK Whisenant, S Bleiziffer… - European heart …, 2019 - academic.oup.com
Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR)
for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings …

Transcatheter mitral valve therapy in the United States: a report from the STS-ACC TVT registry

M Mack, JD Carroll, V Thourani, S Vemulapalli… - Journal of the American …, 2021 - jacc.org
Data for nearly all patients undergoing transcatheter edge-to-edge repair (TEER) and
transcatheter mitral valve replacement (TMVR) with an approved device in the United States …

2-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation

DWM Muller, P Sorajja, A Duncan, B Bethea… - Journal of the American …, 2021 - jacc.org
Background Transcatheter mitral valve replacement (TMVR) is feasible for selected patients
with severe mitral regurgitation (MR) who are poor candidates for valve surgery …

Prosthesis–patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS/ACC TVT registry

HC Herrmann, SA Daneshvar, GC Fonarow… - Journal of the American …, 2018 - jacc.org
Background: Prosthesis–patient mismatch (PPM) after surgical aortic valve replacement
(AVR) for aortic stenosis is generally associated with worse outcomes. Transcatheter AVR …